Apoptosis Antibodies
Apoptosis refers to the set of ordered biochemical and physical changes in a cell during a specific form of cell death. These changes begin with the rounding and shrinking of the affected cells causing them to lose contact with their neighbors. Later, their endoplasmic reticulum swells and the cisternae begin to form vesicles and vacuoles. In the nucleus, the chromatin condenses and is digested by endogenous nucleases. The nucleus ultimately disintegrates into fragments which are encapsulated into apoptotic bodies. By this point, the plasma membrane has become convoluted and begins blebbing off, forming the surface of the apoptotic bodies, which are then recognized and engulfed by phagocytic cells. In contrast, during necrosis the cell swells and disintegrates in a disordered manner, leading to the destruction of cellular organelles and the rupture of the plasma membrane.
ProSci has a wide variety of apoptosis antibodies. These include antibodies against p53 upregulated modulator of apoptosis (PUMA), Bim, members of the caspase family, death receptors, p53 and many other apoptosis proteins. Additionally, ProSci offers a BAFF and Receptor Detection Set and a TRAIL and Receptor Detection set. ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each apoptosis antibody.
Also, we have a TRAIL and TRAIL receptor flyer in the posters section of our resources area of the ProSci website and our TRAIL and TRAIL receptor products were featured in our May 2006 newsletter which is also in the posters section of our resources area.
Apoptosis Antibodies from ProSci:
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| DAD1 Antibody | 3313 | E, WB, ICC, IF | H, M | (CT) An inhibitor of apoptosis |
| DAP3 Antibody | 45-046 | E, WB | H | (CT) DAP3 |
| DAPK2 Antibody | 2323 | E, WB, IHC | H, M, R | (CT) Death-Associated Protein kinase 2 |
| DAXX Antibody | 49-419 | E, WB, IHC, IF | M, R | Death-associated Protein 6 |
| Daxx Antibody | 1163 | E, WB, ICC | H, M | (CT) Adapter Molecule |
| DcR1 Antibody | 2179 | E, WB, ICC, IF | H, M, R | (ED) Decoy Receptor 1 for TRAIL |
| DcR1 Antibody | 2299 | E, WB, IF | H, M, R | (ED2) Decoy Receptor 1 for TRAIL |
| DcR2 Antibody | 2021 | E, WB, ICC | H, M, R | (ID) Decoy Receptor 2 for TRAIL |
| DcR3 Antibody | 2140 | E, WB, IHC | H, M, R | (NT) Decoy Receptor for FASL and LIGHT |
| DcTRAIL-R2 (MAb Lucy-1) Antibody | XA-1026 | FC | M | monoclonal to DcTRAIL-R2 (mouse) (Lucy-1) |
| DDX41 Antibody | 28-493 | E, WB | H, M, R, D | DDX41 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 41) |
| Death Domain Receptor Detection Set | PSI-1825 | WB, IHC | see datasheet | DR3, DR4, DR5, DR6, DcR1, DcR2, DcR3 |
| DEDAF Antibody | 2227 | E, WB, IHC, IF | H, M, R | A novel regulator of apoptosis |
| DEDD2 Antibody | 3071 | E, WB | H, M, R | (NT) A novel death effector domain containing prot |
| DELE Antibody | 6919 | E, WB, IF | H, R | (NT) Death ligand signal enhancer |
| DFF40 Antibody | 2155 | E, WB, ICC | H, M, R | (IN) Caspase Activated DNase |
| DFF40 Antibody | 2107 | E, WB, ICC | H, M, R | (IN) Caspase Activated DNase |
| DFF40 Antibody | 2153 | E, WB, ICC, IF | H | (NT) Caspase Activated DNase |
| DFF45 Antibody | 1148 | E, WB | H | (NT) DNA fragmentation factor & Inhibitor of CAD |
| DFF45 Antibody | 1141 | E, WB, ICC | H | (CT) DNA fragmentation factor & Inhibitor of CAD |
| DIDO1 Antibody | 28-212 | E, WB | H | DIDO1 (death inducer-obliterator 1) |
| DIDO1 Antibody | 29-082 | E, WB | H, M, R | DIDO1 (death inducer-obliterator 1) |
| DNase II Antibody | 2059 | E, WB, IHC | H | DNase involved in apoptosis |
| DPF1 Antibody | 28-079 | E, WB | H, M, R, D | DPF1 (D4, zinc and double PHD fingers family 1) |
| DPF2 Antibody | 25-449 | E, WB | H, M, R | DPF2 (D4, zinc and double PHD fingers family 2) |
| DPF2 Antibody | 31-266 | E, WB | H | DPF2 (D4, zinc and double PHD fingers family 2) |
| DR3 Antibody | 1166 | E, WB | H, M | (NT) Cell Death Receptor |
| DR3 Antibody | 1120 | E, WB | H, M, R | (CT) Cell Death Receptor |
| DR3 Antibody | 1158 | E, WB, ICC, IF | H, M | (ED) Cell Death Receptor |
| DR4 Antibody | 1139 | E, WB, ICC | H | (CT) Death Receptor for TRAIL |
| DR4 Antibody | 1167 | E, WB | H | (NT) Death Receptor for TRAIL |
| DR5 Antibody | 2019 | E, WB, ICC, IF | H, M | (CT) Death Receptor for TRAIL |
| DR6 (MAb Luke-1) Antibody | XA-1015 | FC | H | monoclonal to DR6 (Luke-1) |
| DR6 Antibody | 2157 | E, WB | H | Cell Death Receptor 6 |
| DRAK1 Antibody | 2147 | E, WB, ICC, IF | H | (NT) DAPK Related Apoptosis-inducing Kinase |
| DRAK2 Antibody | 2149 | E, WB, ICC | H | (CT) DAPK Related Apoptosis-inducing Kinase |
| DRAK2 Antibody | 42-010 | E, WB | H | (IN) DRAK2 |
| DRAM Antibody | 4035 | E, WB, IHC, IF | H, M, R | (NT) Damage-regulated autophagy modulator |
| DRAM Antibody | 4033 | E, WB, IHC, IF | H, M, R | (CT) Damage-regulated autophagy modulator |
| DTX2 Antibody | 29-852 | E, WB | H, D, ZF | DTX2 (deltex homolog 2 (Drosophila)) |
| DYRK2 Antibody | 6257 | E, WB, ICC, IF | H | (CT) Dual-specificity tyrosine phosphorylation-reg |

